Hairy cell leukemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
{{CMG}} {{AE}}{{HL}}
{{CMG}} {{AE}}{{HL}}


{{SK}} Leukaemic reticuloendotheliosis; reticuloendotheliosis, leukemic; histiocytic leukemia; malignant reticulosis; lymphoid myelofibrosis
{{SK}} Leukaemic reticuloendotheliosis; Reticuloendotheliosis leukemic; Histiocytic leukemia; Malignant reticulosis; Lymphoid myelofibrosis


==[[Hairy cell leukemia overview|Overview]]==
==[[Hairy cell leukemia overview|Overview]]==

Revision as of 11:07, 21 October 2015

For patient information click here.


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Synonyms and keywords: Leukaemic reticuloendotheliosis; Reticuloendotheliosis leukemic; Histiocytic leukemia; Malignant reticulosis; Lymphoid myelofibrosis

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hairy cell leukemia from other Diseases

Risk Factors

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case#1

Related chapters

External Links

Template:Hematology

de:Haarzellleukämie it:Tricoleucemia nl:Haarcelleukemie fi:Karvasoluleukemia sv:Hårcellsleukemi


Template:WikiDoc Sources